Drugdiscovery >> Drugs >> News
4900
Views
Nasacort  allergy nasal spray approved for OTC in US - drugdiscovery.com
Nasacort allergy nasal spray approved for OTC in US - drugdiscovery.com


The FDA has approved Sanofi’s nasal spray as an over-the-counter (OTC) treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.
Read More >>


Tags: Sanofi, nasal spray, nasacort, OTC, allergy - November 29, 2013
Related Articles
3827
Views
Nasacort now available over-the-counter in USA Nasacort now available over-the-counter in USA
FDA approved Sanofi's allergy drug to switch to OTC. Unlike other allergy medications that have previously been prescription-only but are not available over-the-counter, this is the first steroid medi Read More >>

Tags: Nasacort, Sanofi, allergy drug

3295
Views
Blood pressure drugs plus allergy - it might even be lethal Blood pressure drugs plus allergy - it might even be lethal
Several common blood pressure drugs can be a lethal combo for if you suffer from certain type of allergy. Doctors warn us to pay attention to side effects which might be difficult to find. Read More >>

Tags: drug discovery, doctors, blood pressure drugs, allergy, side effect

4609
Views
EMA Committee gives positive opinion on flu vaccine spray for children EMA Committee gives positive opinion on flu vaccine spray for children
The EMA Committee gave positive opinion on AstraZeneca’ Fluenz Tetra, a nasally administered four-strain live attenuated influenza vaccine, for the prevention of seasonal influenza in eligible child Read More >>

Tags: Astra Zeneca, EU, positive opinion, Fluenz Tetra, flu vaccine

14803
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

10473
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

6347
Views
Remicade Copies Approved in Europe Remicade Copies Approved in Europe
J&J’s Remicade, a drug for arthritis, will have cheaper versions made and sold by two other companies in Europe by 2014. Read More >>

Tags: Remicade, Arthritis, Celltrion, Hospira

12095
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

7595
Views
Astellas’ diarrhea drug - Irribow approved in Japan Astellas’ diarrhea drug - Irribow approved in Japan
Astellas Pharma announced the approval of the additional formulation of Irribow OD Tablets for treatment of diarrhea-predominant irritable bowel syndrome in Japan. Read More >>

Tags: Irribow, Astellas, diarrhea, irritable bowel syndrome, approval

13332
Views
New  erectile dysfunction drug approved  in Ireland and the Netherlands New erectile dysfunction drug approved in Ireland and the Netherlands
Apricus Biosciences has been granted marketing authorization for Vitaros(R) indicated for the treatment of patients with erectile dysfunction. It is already approved in Sweden and the United Kingdom Read More >>

Tags: Vitaros, Apricus Biosciences, erectile dysfunction, approval, marketing authorization

5685
Views
Bayer’s Stivarga approved in Japan Bayer’s Stivarga approved in Japan
Stivarga (regorafenib) has been approved for the treatment of patients with gastrointestinal stromal tumor (GIST) who have progressed after prior systemic cancer therapy. This is the second indication Read More >>

Tags: Stivarga, regorafenib, Bayer, Japan, GIST, gastrintestinal stromal tumor, colorectal cancer, metastatic

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013